The operation signature regulation in force in China means giving the right of signature agreeing to the operation to a third party including the patients family. This kind of practice not only goes against the principle of informed consent and relevant regulations as stipulated in the General Rules of the Civil Law of the Peoples Republic of China and the Contract Law of the Peoples Republic of China, but is also likely to cause medical disputes. For this reason, the signatory right agreeing to the operation ought to belong to the patient himself unless it is a legal matter.

Recently, many Chinese doctors have treated metabolic syndrome from pathogenic phlegm, dampness, stasis and heat, which not only meets the theory of TCM, but also has achieved good clinical effects, besides the method has been confirmed by animal experiments..

Objective To explore the the influence ofFurong-Tongmai capsules on myocardial expression of LN and CollagenⅢ in diabetes mellitus (DM) rats.Methods A total of 60 rats were randomly divided into the control group, the model group, the low-, middle- high-dosageFurong-Tongmai capsules group (n=10). The low-, middle-high-dosageFurong-Tongmai group was given 1.4, 0.7, 2.8 g/(kg body weight) Furong-Tongmai capsules. The other two groups were given the same dose of purified water. After 8 weeks treatment, the myocardial was taken to make pathology slice with SP immunohistochemistry staining. The expression of LN and CollagenⅢ were detected.Results Compared with model group, the expression of LN (0.67% ± 0.04%,0.65% ± 0.09%vs. 1.08% ± 0.13%) and CollagenⅢ (0.67% ± 0.15%, 0.69% ± 0.13%vs. 1.17% ± 0.12%) in the middle-high-dosageFurong-Tongmai groups significantly decreased (P<0.05). However, there were no statistical differences between the low-, middle- high-dosageFurong-Tongmai groups and the model group (P>0.05).Conclusions TheFurong-Tongmai capsules could inhibit the expression of LN and CollagenⅢ in DM rats.